sq-11725 has been researched along with Animal Mammary Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abudarham, N; Ben-Eliyahu, S; Melamed, R; Rosenne, E; Schwartz, Y; Shakhar, K | 1 |
1 other study(ies) available for sq-11725 and Animal Mammary Carcinoma
Article | Year |
---|---|
Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Animals; Cell Line, Tumor; Cyclooxygenase Inhibitors; Dinoprostone; Drug Therapy, Combination; Female; Indomethacin; Killer Cells, Natural; Laparotomy; Lung; Lung Neoplasms; Male; Mammary Neoplasms, Animal; Nadolol; Neoplasm Transplantation; Neoplastic Cells, Circulating; Postoperative Complications; Rats; Rats, Inbred F344 | 2005 |